The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Neurocrine Biosciences, Inc. (Nasdaq: NBIX), today announced positive topline data for its Phase 2 SAVITRI™ study. This randomized, double-blind, ...
read more
Abbvie Inc., Aspen Pharmacare Holdings Ltd and Aurobindo Pharma Ltd., and More to Emerge as Some of the Key Vendors
read more
Endevica Bio, a company developing first-in-class peptide drug candidates, announced its novel weight-loss treatment was successful in a recent diet-...
read more
Amylyx Pharmaceuticals, Inc. announced the company has started a process with the U.S. FDA and Health Canada to voluntarily discontinue the marketing ...
read more
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of ...
read more
FAonline INC is voluntarily recalling all lots within expiry of the ForeverMen capsules to the consumer level. FDA analysis founds these products to ...
read more
Wednesday, April 10, 2024
Charles River Laboratories International, Inc. announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with ...
read more
Wednesday, April 10, 2024
BrainStorm Cell Therapeutics Inc. , a developer of adult stem cell therapeutics for neurodegenerative diseases, announced that it received written ...
read more
Wednesday, April 10, 2024
Essential Pharma, a specialty pharma group has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd. Renaissance ...
read more
Wednesday, April 10, 2024
Ascend Advanced Therapies has acquired the CMC team and site in Alachua, Florida from Beacon Therapeutics. The transaction brings an operational good ...
read more
Wednesday, April 10, 2024
Lisata Therapeutics, Inc. announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (“ODD”) to LSTA1, the Company’s ...
read more
Wednesday, April 10, 2024
Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk under a framework agreement that initially is contemplated to ...
read more
UroGen Pharma Ltd. announced that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Teva Pharmaceuticals, Inc., ...
read more
Biognosys, a provider of mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a company powering precision proteomics to enable the ...
read more
Diagonal Therapeutics has launched with $128 million in financing. The Series A was co-led by BVF Partners and Atlas Venture, with participation from ...
read more